M
145,9-234,2 mil US$ / año · Cambridge, Massachusetts, US
Moderna develops and commercialises mRNA-based medicines and vaccines, with approved products for COVID-19 and RSV and 45 development programmes across infectious disease, oncology and other areas.
1 oferta